Basal and cycle androgen levels correlate with in vitro fertilization stimulation parameters but do not predict pregnancy outcome.

OBJECTIVE To evaluate androgen levels before and during IVF. To assess for an association between androgen levels and IVF stimulation parameters or IVF pregnancy outcome. DESIGN Prospective cohort study. SETTING Residency-based IVF program. PATIENT(S) One hundred seventeen infertility patients. INTERVENTION(S) Androgen levels were evaluated on basal day 3 and during the IVF stimulation cycle. MAIN OUTCOME MEASURE(S) Pregnancy outcome rates and IVF stimulation parameters. RESULT(S) Mean serum androgen levels did not differ among different pregnancy outcomes. Multiple linear regression analysis revealed that body mass index (BMI) and oocyte number had a significant positive association with basal testosterone levels. Mean ovarian volume correlated negatively and follicle number correlated positively with testosterone levels on day 6 of stimulation. Peak E(2) and BMI correlated positively with testosterone on day of hCG administration. The interval change in androgen levels throughout the IVF cycle was not associated with outcome rates. Likewise, threshold analysis did not reveal any significant androgen level that affected pregnancy outcome. CONCLUSION(S) Serum androgen levels during IVF correlate with IVF stimulation parameters. However, these data do not support an influence of serum androgen levels on IVF pregnancy outcome rates.

[1]  Z. Rosenwaks,et al.  Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. , 1989, Fertility and sterility.

[2]  R. Scott,et al.  Efficacy of selection criteria for ovarian reserve screening using the clomiphene citrate challenge test in a tertiary fertility center population. , 1996, Fertility and sterility.

[3]  D. Navot,et al.  Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonist during ovulation induction for in vitro fertilization. , 1994, Fertility and sterility.

[4]  S. Oehninger,et al.  Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization , 1990 .

[5]  J. Segars,et al.  Microdose follicular phase gonadotropin-releasing hormone agonist (GnRH-a) compared with luteal phase GnRH-a for ovarian stimulation at in vitro fertilization. , 1999, Fertility and sterility.

[6]  W J Bremner,et al.  Reproductive aging: accelerated ovarian follicular development associated with a monotropic follicle-stimulating hormone rise in normal older women. , 1996, The Journal of clinical endocrinology and metabolism.

[7]  Z. Rosenwaks,et al.  Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. , 1995, Fertility and sterility.

[8]  J. Frattarelli,et al.  Effect of androgen levels on in vitro fertilization cycles. , 2004, Fertility and sterility.

[9]  C. Coulam,et al.  Total and free testosterone during pregnancy. , 1980, American journal of obstetrics and gynecology.

[10]  S. Muasher,et al.  Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age. , 1991, Fertility and sterility.

[11]  Z. Rosenwaks,et al.  Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization , 1989 .

[12]  J. Segars,et al.  Prognostic use of mean ovarian volume in in vitro fertilization cycles: a prospective assessment. , 2004, Fertility and sterility.

[13]  D. Navot,et al.  Evaluation of the significance of the estradiol response during the clomiphene citrate challenge test. , 1993, Fertility and sterility.

[14]  J. Hall,et al.  Prognostic value of day 3 estradiol on in vitro fertilization outcome. , 1995, Fertility and sterility.

[15]  J. Segars,et al.  A prospective assessment of the predictive value of basal antral follicles in in vitro fertilization cycles. , 2003, Fertility and sterility.

[16]  P. Serhal,et al.  Simultaneous evaluation of basal follicle-stimulating hormone and 17 beta-estradiol response to gonadotropin-releasing hormone analogue stimulation: an improved predictor of ovarian reserve. , 1998, Fertility and sterility.

[17]  E. Loumaye,et al.  Prediction of individual response to controlled ovarian hyperstimulation by means of a clomiphene citrate challenge test. , 1990, Fertility and sterility.

[18]  R. Scott,et al.  A Prospective Evaluation of Clomiphene Citrate Challenge Test Screening of the General Infertility Population , 1993, Obstetrics and gynecology.

[19]  Z. Rosenwaks,et al.  PROGNOSTIC ASSESSMENT OF FEMALE FECUNDITY , 1987, The Lancet.

[20]  N. Klein,et al.  The Gonadotropin Secretion Pattern in Normal Women of Advanced Reproductive Age in Relation to the Monotropic FSH Rise , 1996, The Journal of the Society for Gynecologic Investigation: JSGI.

[21]  F. Sharara,et al.  Evaluation of basal estradiol levels in assisted reproductive technology cycles. , 2000, Fertility and sterility.

[22]  N. Fournet,et al.  Ovulation induction in women age 40 and older: The importance of basal follicle‐stimulating hormone level and chronological age , 1993 .

[23]  J. Dumoulin,et al.  Elevated levels of basal estradiol-17beta predict poor response in patients with normal basal levels of follicle-stimulating hormone undergoing in vitro fertilization. , 1998, Fertility and sterility.

[24]  R. Scott,et al.  Prognostic assessment of ovarian reserve. , 1995, Fertility and sterility.

[25]  R. Scott,et al.  Basal antral follicle number and mean ovarian diameter predict cycle cancellation and ovarian responsiveness in assisted reproductive technology cycles. , 2000, Fertility and sterility.

[26]  D. Navot,et al.  Infertility: Life table analysis of pregnancy rates in a general infertility population relative to ovarian reserve and patient age , 1995 .

[27]  G. Lambert-Messerlian,et al.  Differential secretion of dimeric inhibin in cultured luteinized granulosa cells as a function of ovarian reserve. , 1995, The Journal of clinical endocrinology and metabolism.

[28]  N. Fournet,et al.  Ovulation induction in women age 40 and older: the importance of basal follicle-stimulating hormone level and chronological age. , 1992, Fertility and sterility.